论文部分内容阅读
目的:探讨硫酸镁联合拉贝洛尔对妊娠期高血压综合征患者血压控制及胎儿的影响。方法:选取2016年1月至2017年2月在汝南县人民医院诊断并治疗妊娠期高血压综合征患者128例,将所有患者随机分为研究组63例和对照组65例。研究组采用硫酸镁联合拉贝洛尔联合治疗,对照组采用硫酸镁进行治疗。观察两组患者的血压控制情况,胎心异常等母婴并发症发生率的影响。结果:研究组治疗后收缩压、舒张压、平均动脉压以及心率均低于对照组,差异具有统计学意义(P<0.05)。研究组剖宫产率、早产、新生儿窒息、围产儿死亡、产后出血以及胎儿胎心异常发生率均低于对照组,差异具有统计学意义(P<0.05)。结论:采用硫酸镁联合拉贝洛尔对妊娠期高血压综合征患者进行治疗,降压效果明显,胎心异常等母婴并发症发生率低。
Objective: To investigate the effects of magnesium sulfate combined with labetalol on blood pressure control and fetus in patients with gestational hypertension. Methods: From January 2016 to February 2017, 128 patients with gestational hypertension syndrome were diagnosed and treated in Runan County People’s Hospital. All patients were randomly divided into study group (63 cases) and control group (65 cases). The study group was treated with magnesium sulfate combined with labetalol, while the control group was treated with magnesium sulfate. To observe the two groups of patients with blood pressure control, fetal heart rate abnormalities such as the impact of maternal and child complications. Results: The systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate of the study group were lower than those of the control group after treatment, the difference was statistically significant (P <0.05). Cesarean section rate, premature birth, neonatal asphyxia, perinatal death, postpartum hemorrhage and fetus fetal heart rate were lower in the study group than in the control group, the difference was statistically significant (P <0.05). Conclusion: Magnesium sulfate combined with labetalol for treatment of patients with pregnancy-induced hypertension syndrome, antihypertensive effect, fetal heart rate abnormalities such as low incidence of maternal and child complications.